Percutaneous interventions in high‐risk patients following mustard repair of transposition of the great arteries
Adult
Cardiac Catheterization
Pacemaker, Artificial
Chi-Square Distribution
Cardiac Pacing, Artificial
Infant, Newborn
Infant
Equipment Design
Kaplan-Meier Estimate
Embolization, Therapeutic
Echocardiography, Doppler, Color
3. Good health
03 medical and health sciences
Postoperative Complications
0302 clinical medicine
Child, Preschool
Humans
Equipment Failure
Angioplasty, Balloon, Coronary
Cardiac Surgical Procedures
Child
Device Removal
Echocardiography, Transesophageal
DOI:
10.1002/ccd.23470
Publication Date:
2012-03-14T18:00:47Z
AUTHORS (6)
ABSTRACT
Abstract Objectives To assess safety, efficacy, and intermediate term outcomes of percutaneous interventions in Mustard patients. Background Baffle leaks obstruction are present 20% survivors. Surgical reintervention is associated with high mortality. Methods Retrospective review performed at three adult congenital catheterization programs. Results Overall, 26 catheterizations 29 were 22 patients (mean age 32.4 ± 8.3 years). Previous laser pacemaker lead extraction was successful seven procedures where the risk. Stent placement all 18 systemic venous baffle (SVB) gradient: 6.2 3.4–0.6 1.0 mm Hg; P < 0.01, narrowest diameter 4.5 4.5–17.1 3.9 mm; 0.01). Balloon angioplasty two for pulmonary (PVB) mixed results. leak included device occlusion ( n = 6), coil 1), covered stent 3). Postprocedural residual demonstrated eight. In not appreciable 1‐year follow‐up. No patient experienced or related symptom recurrence follow‐up: 33.4 29.5 months). Complications one death secondary to ventricular arrhythmia 2 days after PVB inferior SVB resolution following placement. Conclusions repair effective likely safer than surgical intervention. can be safely accomplished but common short term. © 2012 Wiley Periodicals Inc.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....